Study paves way for development of macular degeneration cures

Jan 30, 2008

A new study of age-related macular degeneration (AMD), a disease that affects more than nine million Americans, will pave the way for the biopharmaceutical industry to develop better treatments and cures, according to the Foundation Fighting Blindness, which partially funded the research.

“This is the first time that scientists have been able to create an AMD animal model that closely represents the disease in people,” said Stephen Rose, Ph.D., Chief Research Officer, Foundation Fighting Blindness. “Though there are some treatments for the wet form of AMD, we still don’t have a cure for the condition, and millions of people are still at risk of losing their vision to both the dry and wet forms. This new model will greatly enhance the development of better treatments and potentially a cure.”

Researchers at the Cleveland Clinic Lerner College of Medicine used oxidative chemicals to sensitize the immune systems in mice and create AMD . The study is titled “Oxidative damage-induced inflammation initiates age-related macular degeneration,” and was published in the online edition of the scientific journal Nature Medicine on January 27.

Once developed, therapies for the dry form, or early stage of AMD, could be implemented before vision is lost, which would be a dramatic breakthrough in the treatment of the disease, Rose said.

Source: Foundation Fighting Blindness

Explore further: Clipping proteins that package genes may limit abnormal cell growth in tumors

add to favorites email to friend print save as pdf

Related Stories

Prizes honor studies in vision loss, obesity

Sep 21, 2010

(AP) -- Three scientists have won prestigious medical prizes - one for devising a treatment for a major cause of vision loss and two for laying the groundwork for an explosion in obesity research.

New angiogenesis finding may help fight cancer growth

Sep 28, 2006

A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs the formation of blood vessels, or angiogenesis.

'Molecular assassin' targets disease gene

Jul 03, 2006

University of New South Wales researchers have announced they are developing a new class of experimental drug that has the potential to treat a diverse range of health problems, from inflammation and cancer through to eye ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.